You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fludarabine monophosphate

Showing 1 - 25 of 862
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Fludarabine monophosphate, melphalan, Bortezomib
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)

Completed
  • Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem

Completed
  • Leukemia, Acute Lymphoblastic
  • +2 more
  • Allogeneic stem cell transplantation
  • +3 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Nov 19, 2020

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +11 more
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 24, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +20 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 16, 2020

Severe Osteopetrosis Trial in Minneapolis (procedure, drug, radiation)

Completed
Has Results
  • Severe Osteopetrosis
  • umbilical cord blood transplantation
  • +6 more
  • Minneapolis, Minnesota
    University of MInnesota, Fairview
Jul 10, 2019

Primary Myelofibrosis, Myeloproliferative Disorders Trial in Saint-Petersburg (Allogeneic hematopoietic stem cell

Completed
  • Primary Myelofibrosis
  • Myeloproliferative Disorders
  • Allogeneic hematopoietic stem cell transplantation
  • +4 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 3, 2019

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in United States (Crenolanib, Mitoxantrone, Cytarabine)

Completed
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Little Rock, Arkansas
  • +3 more
May 8, 2019

Sickle Cell Disease Trial in Columbus (Fludarabine monophosphate, Rituximab, Busulfan)

Terminated
Has Results
  • Sickle Cell Disease
  • Fludarabine monophosphate
  • +6 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Apr 2, 2019

Leukemia, Chronic Myeloid, MDS, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Trial in Saint-Petersburg (Unrelated

Terminated
  • Leukemia, Chronic Myeloid
  • +2 more
  • Unrelated allogeneic stem cell transplantation
  • +6 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 3, 2019

Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma

Withdrawn
  • Metastatic Bladder Urothelial Carcinoma
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 27, 2019

Inhaled Nitric Oxide Responsiveness in Patients With PPHN

Withdrawn
  • PPHN
  • Hypoxic Respiratory Failure
    • (no location specified)
    Sep 12, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency Trial in New York (Thymidine)

    Active, not recruiting
    • Mitochondrial DNA Depletion Syndrome 2 Myopathic Type
    • Thymidine Kinase 2 Deficiency
    • New York, New York
      Columbia University Irving Medical Center
    Jul 28, 2022

    Rheumatoid Arthritis Trial (Cilostazol, Methotrexate, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • (no location specified)
    Oct 30, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Infusion of NEXI-001 T Cells
    • Duarte, California
    • +4 more
    Feb 16, 2021

    Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    Has Results
    • Stage I Chronic Lymphocytic Leukemia
    • +3 more
    • Scottsdale, Arizona
    • +363 more
    Dec 30, 2022

    Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

    Not yet recruiting
    • Relapsed/Refractory Large B Cell Lymphoma
    • ALLO-647
    • +3 more
    • (no location specified)
    Feb 6, 2023

    Advanced Cancer Trial in Webster (RBS2418)

    Recruiting
    • Advanced Cancer
    • Webster, Texas
      Tranquil Research
    Apr 26, 2022